Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

Saba Saya ,  i ,  Hassan Neishaboo 외 4명

Clinical and Molecular Hepatology

2018 .01

Sitagliptin attenuates endothelial dysfunction independent of its blood glucose controlling effect

Xin-Miao Chang ,  Fei Xiao ,  Qi Pan 외 2명

The Korean Journal of Physiology & Pharmacology

2021 .09

Anti-inflammatory and antinociceptive effects of sitagliptin in animal models and possible mechanisms involved in the antinociceptive activity

Valiollah Hajhashemi ,  Hossein Sadeghi ,  Fatemeh Ka 외 1명

The Korean Journal of Pain

2024 .01

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?

Ho Soo Chun ,  Minjong Lee

Clinical and Molecular Hepatology

2023 .04

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease

노정현

Journal of Obesity & Metabolic Syndrome

2020 .01

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease

Ji-Won Pa ,  k ,  Ki Tae Suk

Clinical and Molecular Hepatology

2023 .04

The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease

Lee Ji Yeon

Gut and Liver

2024 .07

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

Seonghwan Hwang ,  Won Kim

Clinical and Molecular Hepatology

2022 .07

Personalized medicine in nonalcoholic fatty liver disease

Ca ,  los J. Pi ,  ola 외 1명

Clinical and Molecular Hepatology

2022 .10

Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53

Rogalska ,  Aneta ,  Sliwinska 외 9명

Asian Pacific journal of cancer prevention : APJCP

2016 .01

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients

박영환 ,  손민지 ,  이소연 외 1명

Diabetes and Metabolism Journal

2024 .03

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)

박용환 ,  손민지 ,  임수

Diabetes and Metabolism Journal

2024 .09

Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)

이은영

Diabetes and Metabolism Journal

2024 .09

Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations

Soon Sun Kim ,  Jae Youn Cheong

Clinical and Molecular Hepatology

2022 .10

Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus

Chi-Ho Lee ,  Mei-Zhen Wu ,  David Tak-Wai Lui 외 14명

Diabetes and Metabolism Journal

2022 .11

The growing burden of non-alcoholic fatty liver disease on mortality

Ju-Yeon Cho ,  Won Sohn

Clinical and Molecular Hepatology

2023 .04

Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus

Nae Yun Heo

Gut and Liver

2019 .01

Implications of comorbidities in nonalcoholic fatty liver disease

She ,  lot Juan Song ,  Vincent Wai-Sun Wong

Clinical and Molecular Hepatology

2023 .04

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?

Seung Mi Lee ,  Won Kim

Clinical and Molecular Hepatology

2022 .01